Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-112957
Filing Date
2023-04-24
Accepted
2023-04-24 16:40:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d817689ddefa14a.htm DEFA14A 13097
2 GRAPHIC g817689g02n02.jpg GRAPHIC 331264
3 GRAPHIC g817689g03n03.jpg GRAPHIC 176932
  Complete submission text file 0001193125-23-112957.txt   714410
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39485 | Film No.: 23840597
SIC: 2834 Pharmaceutical Preparations